Incidence of liver- and non-liver-related outcomes in patients with HCV-cirrhosis after SVRRoberta D’Ambrosio, Pietro Lampertico, R. Soffredini et al.|Journal of Hepatology|2021Cited by 75
Hepatic Fat—Genetic Risk Score Predicts Hepatocellular Carcinoma in Patients With Cirrhotic HCV Treated With DAAsElisabetta Degasperi, Pietro Lampertico, R. Soffredini et al.|Hepatology|2020Cited by 67
Liver fibrosis and CD206+ macrophage accumulation are suppressed by anti-GM-CSF therapyAlfonso Tan-Garcia, Charles‐Antoine Dutertre, Antonio Bertoletti et al.|JHEP Reports|2019Cited by 64